Inserm CIC 1424, Cayenne Hospital, Centre d'Investigation Clinique Antilles-Guyane, Cayenne, French Guiana.
TBIP, CNRS, Inserm, U1019-UMR9017-CIIL Centre d'Infection et d'Immunité de Lille, Institut Pasteur de Lille, Université de Guyane, Université de Lille, Cayenne, French Guiana.
Malar J. 2023 Aug 16;22(1):237. doi: 10.1186/s12936-023-04672-6.
Scaling-up an experimental intervention is always a challenge. On the border between French Guiana, Brazil and Suriname, an interventional study demonstrated the effectiveness of distributing self-diagnosis and self-treatment kits (Malakits) to control malaria in mobile and hard-to-reach populations. Its integration into the Suriname's National Malaria Elimination Plan after a 2-year experiment faced numerous challenges, including human resources to cope with the additional workload of coordinators and to maintain the motivation of community health workers. The economic recession in Suriname, the Covid pandemic, and logistical issues also hampered the scale-up. Finally, thanks to the commitment of stakeholders in Suriname and French Guiana, the integration of Malakit distribution into the Surinamese national programme was proved possible.
扩大实验干预措施的规模始终是一个挑战。在法属圭亚那、巴西和苏里南三国交界地区，一项干预性研究表明，向流动人口和难以到达地区分发自我诊断和自我治疗工具包（Malakits）来控制疟疾是有效的。在经过 2 年的试验后，该工具包被纳入苏里南国家消除疟疾计划，但面临着诸多挑战，包括人力资源方面的挑战，需要协调员承担更多的工作量并保持社区卫生工作者的积极性。苏里南经济衰退、新冠疫情和后勤问题也阻碍了规模的扩大。最后，由于苏里南和法属圭亚那利益攸关方的承诺，将 Malakit 分发纳入苏里南国家方案成为可能。
